Cargando…

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock

Acute myocardial infarction complicated by cardiogenic shock (AMICS), is characterized by critically low cardiac output and decreased myocardial contractility. In this situation, a treatment that unloads the myocardium and restores CO without increasing the myocardial oxygen demand is theoretically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Møller, Jacob Eifer, Kjaergaard, Jesper, Terkelsen, Christian Juhl, Hassager, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101440/ https://www.ncbi.nlm.nih.gov/pubmed/35566553 http://dx.doi.org/10.3390/jcm11092427

Ejemplares similares

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock
por: Udesen, Nanna Louise Junker, et al.
Publicado: (2022)

Hemodynamic and metabolic recovery in acute myocardial infarction-related cardiogenic shock is more rapid among patients presenting with out-of-hospital cardiac arrest
por: Josiassen, Jakob, et al.
Publicado: (2020)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
por: Saito, Yuichi, et al.
Publicado: (2023)

Cardiogenic Shock Complicating Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention Supported by Impella: Implications of Advanced Age and Refractory Shock on Outcomes
por: Boshara, Andrew, et al.
Publicado: (2021)

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)

Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock
por: Helgestad, Ole Kristian Lerche, et al.
Publicado: (2020)

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
por: O’Neill, William W, et al.
Publicado: (2014)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
por: Batchelor, Riley J., et al.
Publicado: (2022)

Impact of Impella RP Versus Vasoactive Treatment on Right and Left Ventricular Strain in a Porcine Model of Acute Cardiogenic Shock Induced by Right Coronary Artery Embolization
por: Frederiksen, Peter H., et al.
Publicado: (2023)

Invasive Phenoprofiling of Acute-Myocardial-Infarction-Related Cardiogenic Shock
por: Ortega-Hernández, Jorge A., et al.
Publicado: (2023)

Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic()
por: Lauridsen, M.D., et al.
Publicado: (2020)

Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle
por: Josiassen, Jakob, et al.
Publicado: (2020)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery
por: Sicouri, Serge, et al.
Publicado: (2023)

Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience
por: Ouweneel, Dagmar M, et al.
Publicado: (2018)

Sex-Related Differences in Short-Term Prognosis in Patients with Acute Myocardial Infarction-Related Cardiogenic Shock Receiving Impella Support in Japan: From the J-PVAD Registry
por: Nakamura, Makiko, et al.
Publicado: (2023)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

A Review of Cardiogenic Shock in Acute Myocardial Infarction
por: Khalid, L, et al.
Publicado: (2008)

Paraganglioma masquerading as acute myocardial infarction and cardiogenic shock
por: Ahmad, Tanveer, et al.
Publicado: (2016)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Pseudoaneurysm Formation After “Preclose”-Assisted Impella Insertion in a Patient With Cardiogenic Shock
por: Asemota, Daniel, et al.
Publicado: (2022)

ST-Elevation Myocardial Infarction With Cardiogenic Shock and Severe Acute Ischemic Mitral Regurgitation Rescued by Primary Coronary Intervention Under Hemodynamic Support With Impella
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

Support with Impella versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: A protocol for systematic review and meta-analysis
por: Rao, Lingzhang, et al.
Publicado: (2021)

Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis
por: George, Praveen, et al.
Publicado: (2017)

Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience
por: Schwartz, Bryan G., et al.
Publicado: (2012)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Pulmonary artery catheter use in acute myocardial infarction‐cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2020)

Predictors of right ventricular function as measured by tricuspid annular plane systolic excursion in heart failure
por: Kjaergaard, Jesper, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_g1g3j59nno8i4cj2a97m36cpcv